Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 31 Neoplasm Metastasis 17 Liver Neoplasms 14 Colorectal Neoplasms 13 Lung Neoplasms 9 Cholangiocarcinoma 9 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Pancreatic Neoplasms 6 Barrett Esophagus 6 Thyroid Nodule 5 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Leiomyoma 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Hyperaldosteronism 2 Cancer Pain 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Agnosia 2 Adrenocortical Adenoma 2

Interventions

Tamoxifen 3 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389216 2025-09-15

RFA

Hospital Universitari de Bellvitge

Phase NA Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡